Lonza Announces Agreement with Alexion
The addition of a new manufacturing line at Lonza’s Portsmouth, NH site enables Alexion to add dedicated product supply for 10 years.
Lonza Group announced on July 2 a long-term product supply agreement with Alexion under which Lonza will construct and launch a new suite dedicated to Alexion manufacturing at Lonza’s Portsmouth, NH site. Lonza reports the manufacturing line will be operational by the end of 2017
The agreement, and expansion of an existing manufacturing agreement, will supplement existing production of Alexion products at multiple Lonza facilities. Lonza will own and operate the suite at the Portsmouth site.
The expansion of the existing site will provide increased access to Lonza’s biological manufacturing and regulatory expertise, global workforce and customer service. Lonza has more than two decades of manufacturing experience with mammalian biotherapeutics.
Source: Lonza
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
Inspiration Over Desperation: Accurant Biotech CEO Talks Leadership, Innovation, and Motivation
March 4th 2025Xiao-Yan Cai, PhD, shares insights into her leadership style, the importance of motivation in the workplace, and how she balances repetition with innovation, discussing how hobbies and resilience uniquely shape her professional approach, emphasizing the value of perseverance and preparation in both science and life.
